CAMpania PugliA bRanch Iliaco
Launched by FEDERICO II UNIVERSITY · Apr 23, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The CAMpania PugliA bRanch Iliaco trial is a research study looking at how well a specific medical device called the E-liac Branch Device works for treating aortoiliac aneurysms, which are bulges in the blood vessels in the lower part of the abdomen. This study will track the performance of this device over time in real patients to see how effective it is in everyday healthcare settings.
To participate in this trial, patients should have an aortoiliac or aortic aneurysm that needs treatment, and they will be treated with the E-liac stent-graft system, either by itself or along with other devices. The study is open to all adults, and it's important to note that patients who do not wish to join or have been treated with different devices will not be included. Those who take part can expect regular follow-ups to monitor their health and the results of the treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices
- Exclusion Criteria:
- • Patient's refusal to be enrolled in the registry
- • Patient treated with devices not including the E-liac stent-graft system
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
Bari, Ba, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported